FRM
Fox Run Management’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $994K | Sell |
14,224
-10,666
| -43% | -$745K | 0.17% | 192 |
|
|
2025
Q1 | $1.83M | Buy |
24,890
+2,276
| +10% | +$167K | 0.28% | 41 |
|
|
2024
Q4 | $1.48M | Buy |
+22,614
| New | +$1.48M | 0.27% | 59 |
|
|
2024
Q3 | – | Sell |
-12,445
| Closed | -$971K | – | 802 |
|
|
2024
Q2 | $971K | Sell |
12,445
-1,147
| -8% | -$89.5K | 0.18% | 197 |
|
|
2024
Q1 | $921K | Buy |
+13,592
| New | +$921K | 0.2% | 153 |
|
|
2023
Q3 | – | Sell |
-10,130
| Closed | -$725K | – | 704 |
|
|
2023
Q2 | $725K | Buy |
+10,130
| New | +$725K | 0.2% | 170 |
|
|
2023
Q1 | – | Sell |
-7,354
| Closed | -$499K | – | 654 |
|
|
2022
Q4 | $499K | Buy |
+7,354
| New | +$499K | 0.2% | 180 |
|
|
2022
Q1 | – | Sell |
-4,876
| Closed | -$284K | – | 499 |
|
|
2021
Q4 | $284K | Buy |
+4,876
| New | +$284K | 0.17% | 245 |
|
|
2019
Q4 | – | Sell |
-5,682
| Closed | -$253K | – | 384 |
|
|
2019
Q3 | $253K | Buy |
+5,682
| New | +$253K | 0.23% | 218 |
|
|
2019
Q2 | – | Sell |
-18,646
| Closed | -$754K | – | 433 |
|
|
2019
Q1 | $754K | Sell |
18,646
-255
| -1% | -$10.3K | 0.43% | 25 |
|
|
2018
Q4 | $718K | Buy |
+18,901
| New | +$718K | 0.38% | 33 |
|
|
2018
Q3 | – | Sell |
-8,700
| Closed | -$305K | – | 576 |
|
|
2018
Q2 | $305K | Sell |
8,700
-15,562
| -64% | -$546K | 0.1% | 426 |
|
|
2018
Q1 | $848K | Buy |
+24,262
| New | +$848K | 0.21% | 124 |
|
|
2017
Q4 | – | Sell |
-28,100
| Closed | -$952K | – | 669 |
|
|
2017
Q3 | $952K | Buy |
28,100
+4,400
| +19% | +$149K | 0.27% | 80 |
|
|
2017
Q2 | $808K | Buy |
+23,700
| New | +$808K | 0.28% | 85 |
|
|
2016
Q4 | – | Sell |
-12,700
| Closed | -$417K | – | 500 |
|
|
2016
Q3 | $417K | Buy |
+12,700
| New | +$417K | 0.25% | 151 |
|